Tick-Borne Disease

The geographic range of ticks in the United States is expanding, which may place more people than ever at risk for tick-borne diseases. We asked Richard S. Ostfeld, PhD, for an explanation.

Although primary care physicians have basic knowledge of alpha-gal syndrome, results of a small survey suggest that many characteristics of the condition are unknown or misunderstood, according to researchers.

Lyme disease is the most recognized term for tick-borne illness, but the tiny bacterial spirochete that causes Lyme, Borrelia burgdorferi, is but one of many possible co-infections carried by ticks.

July 6 is World Zoonoses Day, which is observed each year on the anniversary of Louis Pasteur administering the first rabies vaccine to a human in 1885.

In this video, Nitin Damle, MD, MS, MACP, past president of the ACP, discusses highlights from his presentation at the virtual ACP Internal Medicine Meeting on the health consequences of climate change.

Tick surveillance and control in the United States are inconsistent, largely because of inconsistent funding, limited infrastructure, lack of guidance and institutional capacity, according to a survey in the Journal of Medical Entomology.

The FDA recently approved an expanded indication of the antiviral drug Xofluza to include patients who are at high risk for developing influenza-related complications, and new community-associated pneumonia guidelines emphasize the importance of de-escalation of antibiotic therapy.

Researchers collected three species of ticks from multiple locations in Suffolk County, Long Island, and identified a high prevalence of polymicrobial infections capable of causing human disease.